Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Dexcom Announces Upcoming Virtual Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences:

  • Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 4:20pm (EST).
  • Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 at 11:20am (EST).
  • Quentin Blackford, Chief Operating Officer and Chief Financial Officer, will present on behalf of the company at the Morgan Stanley 18th Annual Healthcare Conference on Tuesday, September 15, 2020 at 11:00am (EST).

Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com/ and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200904005138/en/

Dexcom Inc. Aktie

73,40 €
0,55 %
Die Dexcom Inc. Aktie notiert heute etwas höher, mit einem Anstieg von 0,55 %.
Deutliches Buy-Überwiegen bei Dexcom Inc. im Vergleich zu Sell-Einschätzungen.
Für Dexcom Inc. ergibt sich ein leicht positives Potenzial, angesichts eines Kursziels von 75 € im Vergleich zu 73.4 €.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare